Search academic texts

Information × Registration Number 0305U001714, 0105U001790 , R & D reports Title Studying efficiency and tolerability of Klasan, tablrts on 0,25 g, 0,5 g production OAT "Kievmedpreparat" in treatment chronic bronchitis intensify phase popup.stage_title Вивчення ефективності і переносимості препарату Класан, таблетки по по 0,25 г, 0,5 г виробництва ВАТ "Київмедпрепарат" в лікуванні хронічного бронхіту в фазі загострення Head Svintsitskiy Anatoliy S., Доктор медичних наук Registration Date 12-04-2005 Organization National Medical University popup.description2 There is open limited clinical research of the drug Klasan, tblets on 0,25 g, 0,5 g, production OAT "Kievmedpreparat" for treatment f patients with chronic bronchitis intensify phase. The drug Klasan, tablets on 0,25 g, 0,5 g production OAt "Kievmedpreparat" was use for 30 patients/ 30 patients o comparative group with analogic diagnosis had treatment with application of the drug Klabaks tablets on 0,25 g, 0,5 g of firm"Ranbaxy Laboratories Limited" (India). It waa found that therapeutic effectioveness and tolerability of drugs Klasa, tablets on 0,25 g, 0,5 g production OAN @Kievmedpreparat" and the drug Klabaks tablets on 0,25 g, 0,5 g of firm "Ranbaxy Laboratories Limited" (India) are equivalent. No complications and adverse effects of use drugs ere observed Product Description popup.authors popup.nrat_date 2020-04-02 Close